Fundz

Insitro, Inc. reported raising $143 Million in an initial SEC Form D filing, from an offering of $143 Million

PRIVATEMay 27, 2020

Amount Raised

$143 Million

$143 Million sold, per SEC Form D (first sale May 27, 2020)

Round Type

Venture

San FranciscoBiotechnologyHealth CareTherapeutics

Quick answer

Insitro raised $143 Million in a funding round, dated May 27, 2020. Insitro is based in San Francisco, California, United States.

How much did Insitro raise?
Insitro raised $143 Million in a funding round on May 27, 2020.
What does Insitro do?
Insitro is an AI therapeutics company focused on drug discovery and development.
Where is Insitro based and how big is it?
Insitro is based in San Francisco, California, United States.
Who are the decision-makers at Insitro?
Fundz holds 1 contact at Insitro. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Insitro that raised within 45 days of this round, from Fundz verified event records.

  • Artiva Biotherapeutics raised $43M on July 10, 2020.
  • Vor Bio raised $110M on July 10, 2020.
  • Aura Biosciences, Inc. raised $10M on July 9, 2020.
  • Inimmune Corporation raised $22M (Series A) on July 9, 2020.
  • Vor Bio raised $110M (Series B) on July 7, 2020.
  • Fate Therapeutics raised $50M on July 6, 2020.

Who to call at Insitro, and when

A new round usually means Insitro is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Insitro raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Insitro, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Insitro. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Insitro

Location

279 East Grand Avenue, Suite 200

San Francisco, California, United States

About

Insitro is an AI therapeutics company focused on drug discovery and development. The company utilizes machine learning techniques to enhance and expedite the process of pharmaceutical research. Insitro aims to transform the way drugs are discovered and developed, improving outcomes in healthcare. It has garnered respect in the biotech industry for its innovative approach.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Insitro raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Insitro. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Insitro's next move

See what Strategic adds

Insitro raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.